A collaboration to provide an enhanced framework of regulatory genomic elements in individuals with neuropsychiatric disorders
The PsychENCODE Consortium is a collaboration between 16 institutions working to provide an enhanced framework of regulatory genomic elements in individuals with neuropsychiatric disorders.
A set of eleven manuscripts in Science, Science Translational Medicine and Science Advances is the culmination of work by the PsychENCODE Consortium to provide an enhanced framework of regulatory genomic elements in individuals with neuropsychiatric disorders.
The PsychENCODE program is funded by the NIMH with the goal of accelerating discovery of non-coding functional genomic elements in human brain, and elucidating their role in the molecular pathophysiology of psychiatric disorders. The Consortium investigators are producing a public resource of multi-dimensional genomic data using unbiased genome-wide approaches on tissue and cell-type specific samples from approximately 1000 phenotypically well-characterized healthy and diseased human post-mortem brains. The Consortium is also sharing data from functional characterization of disease-associated regulatory elements and variants in in-vitro and in-vivo model systems.
More Scientific Coordination Projects
Multi-Consortia Coordinating (MC2) Center
Sage Bionetworks leads the Multi-Consortia Coordinating (MC2) Center for six research consortia from the NIH/NCI Division of Cancer Biology. The MC2 Center aims to catalyze...Learn More
The Gray Foundation
The Gray Foundation "Team Science" philanthropic initiative funds a network of researchers to study new approaches for the early detection, diagnosis, and therapy of BRCA-related...Learn More
The First 1000 Days 1kD
The 1kD program is an international effort to better understand executive development in toddlers up to 1000 days old.Learn More